Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takefumi Kitazawa is active.

Publication


Featured researches published by Takefumi Kitazawa.


Journal of Hospital Medicine | 2012

Risk factors of workplace violence at hospitals in Japan

Shigeru Fujita; Shinya Ito; Kanako Seto; Takefumi Kitazawa; Kunichika Matsumoto; Tomonori Hasegawa

BACKGROUND Patients and their relatives exposed to mental stress caused by hospitalization or illness might use violence against healthcare staff and interfere with quality healthcare. OBJECTIVE The aim of this study was to investigate incidences of workplace violence and the attributes of healthcare staff who are at high risk. DESIGN A questionnaire-based, anonymous, and self-administered cross-sectional survey. SETTING Healthcare staff (n = 11,095) of 19 hospitals in Japan. MEASUREMENTS Incidence rates and adjusted odd ratios of workplace violence were calculated to examine the effect of attributes of healthcare staff to workplace violence by using logistic regression analysis. RESULTS The response rate for survey completion was 79.1% (8711/11,095). Among the respondents, 36.4% experienced workplace violence by patients or their relatives in the past year; 15.9% experienced physical aggression, 29.8% experienced verbal abuse, and 9.9% experienced sexual harassment. Adjusted odds ratios of physical aggression were significantly high in psychiatric wards, critical care centers/intensive care units (ICU)/cardiac care units (CCU), long-term care wards, for nurses, nursing aides/care workers, and for longer working hours. Adjusted odds ratios of verbal abuse were significantly high in psychiatric wards, long-term care wards, outpatient departments, dialysis departments, and for longer years of work experience, and for longer working hours. Adjusted odds ratios of sexual harassment were significantly high in dialysis departments, for nurses, nursing aides/care workers, technicians, therapists and females. The general ward and direct interaction with patients were common risk factors for each type of workplace violence. CONCLUSIONS The mechanisms and the countermeasures for each type of workplace violence at those high-risk areas should be investigated.


BMC Health Services Research | 2013

Cost of illness of the stomach cancer in Japan - a time trend and future projections

Kayoko Haga; Kunichika Matsumoto; Takefumi Kitazawa; Kanako Seto; Shigeru Fujita; Tomonori Hasegawa

BackgroundStomach cancer is one of the leading causes of cancer deaths in Japan. The objectives of this study were to estimate and project the economic burden associated with stomach cancer in Japan, and to identify the key factors that drive the economic burden of stomach cancer.MethodsWe calculated Cost of illness (COI) of 1996, 2002, 2008, 2014 and 2020 by using government office statistics and the COI method. We calculated direct cost and indirect cost (morbidity cost and mortality cost), and estimated the COI by summing them up.ResultsThe number of deaths remained at approximately 50,000 in 1996–2008. COI was in downward trend from 1,293.5 billion yen in 1996 to 1,114.2 billion yen in 2008. Morbidity cost was 85.6 billion yen and 54.0 billion yen, mortality cost was 972.3 billion yen and 806.4 billion yen, and mortality cost per person was 19.4 million yen and 16.1 million yen in 1996 and 2008, respectively. Decrease of mortality cost that accounted for a large part of the COI (72.4% in 2008) was the major contributing factor. COI is predicted to decrease if the trend of health related indicators continues (442.8-1,056.1 billion yen depending on the model in 2020). Mortality cost per person is also predicted to decrease (9.5-12.5 million yen depending on the model in 2020).ConclusionsIf the trend of health related indicators continues, it is estimated that COI of stomach cancer would decrease. “Aging”, “change of the healthcare providing system” and “new medical technology” are considered as contributing factors of COI.


BMC Health Services Research | 2014

Characteristics of unit-level patient safety culture in hospitals in Japan: a cross-sectional study

Shigeru Fujita; Kanako Seto; Takefumi Kitazawa; Kunichika Matsumoto; Tomonori Hasegawa

BackgroundPatient safety culture (PSC) has an important role in determining safety and quality in healthcare. Currently, little is known about the status of unit-level PSC in hospitals in Japan. To develop appropriate strategies, characteristics of unit-level PSC should be investigated. Work units may be classified according to the characteristics of PSC, and common problems and appropriate strategies may be identified for each work unit category. This study aimed to clarify the characteristics of unit-level PSC in hospitals in Japan.MethodsIn 2012, a cross-sectional study was conducted at 18 hospitals in Japan. The Hospital Survey on Patient Safety Culture questionnaire, developed by the United States Agency for Healthcare Research and Quality, was distributed to all healthcare workers (n =12,076). Percent positive scores for 12 PSC sub-dimensions were calculated for each unit, and cluster analysis was used to categorise the units according to the percent positive scores. A generalised linear mixed model (GLMM) was used to analyse the results of the cluster analysis, and odds ratios (ORs) for categorisation as high-PSC units were calculated for each unit type.ResultsA total of 9,124 respondents (75.6%) completed the questionnaire, and valid data from 8,700 respondents (72.0%) were analysed. There were 440 units in the 18 hospitals. According to the percent positive scores for the 12 sub-dimensions, the 440 units were classified into 2 clusters: high-PSC units (n =184) and low-PSC units (n =256). Percent positive scores for all PSC sub-dimensions for high-PSC units were significantly higher than those for low-PSC units. The GLMM revealed that the combined unit type of `Obstetrics and gynaecology ward, perinatal ward or neonatal intensive care unit’ was significantly more likely to be categorised as high-PSC units (OR =9.7), and `Long-term care ward’ (OR =0.2), `Rehabilitation unit’ (OR =0.2) and `Administration unit’ (OR =0.3) were significantly less likely to be categorised as high-PSC units.ConclusionsOur study findings demonstrate that PSC varies considerably among different unit types in hospitals in Japan. Factors contributing to low PSC should be identified and possible measures for improving PSC should be developed and initiated.


BMC Research Notes | 2014

Perioperative patient safety indicators and hospital surgical volumes

Takefumi Kitazawa; Kunichika Matsumoto; Shigeru Fujita; Ai Yoshida; Shuhei Iida; Hirotoshi Nishizawa; Tomonori Hasegawa

BackgroundSince the late 1990s, patient safety has been an important policy issue in developed countries. To evaluate the effectiveness of the activities of patient safety, it is necessary to quantitatively assess the incidence of adverse events by types of failure mode using tangible data. The purpose of this study is to calculate patient safety indicators (PSIs) using the Japanese Diagnosis Procedure Combination/per-diem payment system (DPC/PDPS) reimbursement data and to elucidate the relationship between perioperative PSIs and hospital surgical volume.MethodsDPC/PDPS data of the Medi-Target project managed by the All Japan Hospital Association were used. An observational study was conducted where PSIs were calculated using an algorithm proposed by the US Agency for Healthcare Research and Quality. We analyzed data of 1,383,872 patients from 188 hospitals who were discharged from January 2008 to December 2010.ResultsAmong 20 provider level PSIs, four PSIs (three perioperative PSIs and decubitus ulcer) and mortality rates of postoperative patients were related to surgical volume. Low-volume hospitals (less than 33rd percentiles surgical volume per month) had higher mortality rates (5.7%, 95% confidence interval (CI), 3.9% to 7.4%) than mid- (2.9%, 95% CI, 2.6% to 3.3%) or high-volume hospitals (2.7%, 95% CI, 2.5% to 2.9%). Low-volume hospitals had more deaths among surgical inpatients with serious treatable complications (38.5%, 95% CI, 33.7% to 43.2%) than high-volume hospitals (21.4%, 95% CI, 19.0% to 23.9%). Also Low-volume hospitals had lower proportion of difficult surgeries (54.9%, 95% CI, 50.1% to 59.8%) compared with high-volume hospitals (63.4%, 95% CI, 62.3% to 64.6%). In low-volume hospitals, limited experience may have led to insufficient care for postoperative complications.ConclusionsWe demonstrated that PSIs can be calculated using DPC/PDPS data and perioperative PSIs were related to hospital surgical volume. Further investigations focusing on identifying risk factors for poor PSIs and effective support to these hospitals are needed.


Journal of Obstetrics and Gynaecology Research | 2016

Informing health policy in Japan: A mixed-model estimation to compare the cost of illness of cervical cancer and endometrial cancer

Eijiro Hayata; Kanako Seto; Takefumi Kitazawa; Kunichika Matsumoto; Mineto Morita; Tomonori Hasegawa

The objective of this study was to inform Japanese health policy by comparing cervical cancer and endometrial cancer from the standpoint of economic burden and examining factors affecting future changes in economic burden.


Hepatology Research | 2018

Cost of illness of the non-alcoholic liver cirrhosis in Japan - a time trend analysis and future projections

Takefumi Kitazawa; Kunichika Matsumoto; Shigeru Fujita; Kanako Seto; Yinghui Wu; Tomohiro Hirao; Tomonori Hasegawa

Liver cirrhosis is a preneoplastic condition to hepatocellular carcinoma that is an important worldwide public health concern, and its economic burden has been estimated in some countries. The objective of this study was to estimate and predict the cost of illness (COI) associated with non‐alcoholic liver cirrhosis in Japan.


Surgery Today | 2018

Effects of the concentration of digestive surgical operations in regional Japan

Takefumi Kitazawa; Kunichika Matsumoto; Shigeru Fujita; Kanako Seto; Yinghui Wu; Takayoshi Nagahama; Tomonori Hasegawa

PurposeThe purpose of this study was to investigate the relationship between the concentration of digestive system surgery and outcomes at a regional level in Japan, using time-series data.MethodsWe used nationwide data from 2008 to 2013, and analyzed the ten most common surgical procedures. The unit of analysis was secondary medical areas (SMAs), which cover several municipalities and provide medical services for common diseases. The concentration of surgery in these areas was measured using the Herfindahl–Hirschman Index (HHI) and the relationship between the concentration of surgery and length of stay in hospital (LOS) was analyzed, in accordance with surgical difficulty.ResultsThere was a downward trend in both the HHI and LOS from 2008 to 2013. SMAs showing an upward trend in the HHI (increased concentration) were associated with a greater reduction in LOS than those showing a downward trend for eight surgical procedures. For three easy surgical procedures, increased concentration of surgery was significantly associated with a reduction in LOS. After adjustment for trends in the aging population and the surgical volume in 2008, an increasing concentration for three easy surgical procedures was significantly related to a reduction in the LOS.ConclusionConcentrating relatively easy surgical procedures at a regional level may be associated with a reduction in LOS.


PLOS ONE | 2018

Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections

Kunichika Matsumoto; Yinghui Wu; Takefumi Kitazawa; Shigeru Fujita; Kanako Seto; Tomonori Hasegawa

Background Hepatocellular carcinoma (HCC) is the fifth leading cause of death in Japan. The aim of this study was to calculate the social burden of HCC using the cost of illness (COI) method, and to identify the key factors driving changes in the economic burden of HCC. Methods Utilizing government-based statistical nationwide data, the cost of illness (COI) method was used to estimate the COI for 1996, 1999, 2002, 2005, 2008, and 2014 to make predictions for 2017, 2020, 2023, 2026, and 2029. The COI comprised direct and indirect costs (morbidity and mortality costs) of HCC. Results From 1996 to 2014, COI trended downward. In 2014, COI (579.2 billion JPY) was 0.71 times greater than that in 1996 (816.2 billion JPY). Mortality costs accounted for more than 70% of total COI and were a major contributing factor to the decrease in COI. It was predicted that COI would continue a downward trend until 2029, and that the rate of decline would be similar. Conclusions COI of HCC has been decreasing since 1996. Treatment of patients infected with hepatitis C virus using newly introduced technologies has high therapeutic effectiveness, and will affect the future prevalence of HCC. These policies and technologies may accelerate the downward tendency of COI, and the relative economic burden of HCC is likely to continue to decrease.


Journal of The Chinese Medical Association | 2018

Cost of illness of leukemia in Japan – Trend analysis and future projections

Rebeka Amin; Kunichika Matsumoto; Hiroka Hosaka; Takefumi Kitazawa; Shigeru Fujita; Kanako Seto; Tomonori Hasegawa

Background: Leukemia is a deadly hematological malignancy that usually affects all age groups and imposes significant burden on public funds and society. The objective of this study was to analyze the cost of illness (COI) of leukemia, and to mark out the underlying driving factors, in Japan. Methods: COI method was applied to the data from government statistics. We first summed up the direct and indirect costs from 1996 to 2014; then future COI for the year 2017–2029 was projected. Results: Calculated COI showed an upward trend with a 13% increase from 1996 to 2014 (270–305 billion yen). Increased COI was attributed to an increase in direct costs. Although mortality cost accounted for the largest proportion of COI, but followed a downward trend. Decreased mortality costs reflected the effects of aging. Mortality cost per person also decreased, however, the percentage of mortality cost for individuals ≥65 years of age increased consistently from 1996 to 2014. If a similar trend in health‐related indicators continue, COI would remain stable from 2017 to 2029 regardless of models. Conclusion: COI of leukemia increased from 1996 to 2014, but was projected to decrease in foreseeable future. With advancement of new therapies, leukemia has become potentially curable and require long‐term care; so direct cost and morbidity cost will remain unchanged. This reveal the further continuing burden on public funds. Thus, the information obtained from this study can be regarded as beneficial to future policy making with respect to government policies in Japan.


BMC Research Notes | 2017

Evaluation of clinical practice guidelines using the AGREE instrument: comparison between data obtained from AGREE I and AGREE II

Kanako Seto; Kunichika Matsumoto; Takefumi Kitazawa; Shigeru Fujita; Shimpei Hanaoka; Tomonori Hasegawa

ObjectiveThe Appraisal of Guidelines for Research and Evaluation (AGREE) is a representative, quantitative evaluation tool for evidence-based clinical practice guidelines (CPGs). Recently, AGREE was revised (AGREE II). The continuity of evaluation data obtained from the original version (AGREE I) has not yet been demonstrated. The present study investigated the relationship between data obtained from AGREE I and AGREE II to evaluate the continuity between the two measurement tools.ResultsAn evaluation team consisting of three trained librarians evaluated 68 CPGs issued in 2011–2012 in Japan using AGREE I and AGREE II. The correlation coefficients for the six domains were: (1) scope and purpose 0.758; (2) stakeholder involvement 0.708; (3) rigor of development 0.982; (4) clarity of presentation 0.702; (5) applicability 0.919; and (6) editorial independence 0.971. The item “Overall Guideline Assessment” was newly introduced in AGREE II. This global item had a correlation coefficient of 0.628 using the six AGREE I domains, and 0.685 using the 23 items. Our results suggest that data obtained from AGREE I can be transferred to AGREE II, and the “Overall Guideline Assessment” data can be determined with high reliability using a standardized score of the 23 items.

Collaboration


Dive into the Takefumi Kitazawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge